Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A rational approach to the treatment of ascites.

Literature DB >> 1234341

A rational approach to the treatment of ascites.

V Arroyo, J Rodés.

Abstract

Entities: Disease

Mesh：

Substances：
Diuretics

Year: 1975 PMID： 1234341 PMCID： PMC2496256 DOI： 10.1136/pgmj.51.598.558

Source DB: PubMed Journal: Postgrad Med J ISSN： 0032-5473 Impact factor: 2.401

× No keyword cloud information.

17 in total

1. PROGNOSIS AFTER SURGICAL TREATMENT OF ASCITES: RESULTS OF SIDE-TO-SIDE SHUNT IN 40 PATIENTS.

Authors: H F WELCH; C S WELCH; J H CARTER
Journal: Surgery Date: 1964-07 Impact factor: 3.982

2. THE KIDNEY IN CIRRHOSIS. II. DISORDERS OF RENAL FUNCTION.

Authors: W P BALDUS; R N FEICHTER; W H SUMMERSKILL; J C HUNT; K G WAKIM
Journal: Ann Intern Med Date: 1964-03 Impact factor: 25.391

3. Plasma colloid osmotic pressure in relation to the formation of ascites and oedema in liver disease.

Authors: M ATKINSON; M S LOSOWSKY
Journal: Clin Sci Date: 1962-06 Impact factor: 6.124

4. Renal failure in Laennec's cirrhosis of the liver. I. Description of clinical and laboratory features.

Authors: S PAPPER; J L BELSKY; K H BLEIFER
Journal: Ann Intern Med Date: 1959-10 Impact factor: 25.391

5. Electrolyte and circulatory changes in terminal liver failure.

Authors: R HECKER; S SHERLOCK
Journal: Lancet Date: 1956-12-01 Impact factor: 79.321

6. Hyponatremia in hepatic cirrhosis following paracentesis.

Authors: W P NELSON; J D ROSENBAUM; M B STRAUSS
Journal: J Clin Invest Date: 1951-07 Impact factor: 14.808

7. Complications of diuretic therapy in hepatic cirrhosis.

Authors: S Sherlock; B Senewiratne; A Scott; J G Walker
Journal: Lancet Date: 1966-05-14 Impact factor: 79.321

8. 9- -fluorohydrocortisone induced ascites in alcoholic liver disease.

Authors: E K Denison; F L Lieberman; T B Reynolds
Journal: Gastroenterology Date: 1971-10 Impact factor: 22.682

9. Plasma volume in cirrhosis of the liver: its relation of portal hypertension, ascites, and renal failure.

Authors: F L Lieberman; T B Reynolds
Journal: J Clin Invest Date: 1967-08 Impact factor: 14.808

10. Effective plasma volume in cirrhosis with ascites. Evidence that a decreased value does not account for renal sodium retention, a sponteneous reduction in glomerular filtration rate (GFR), and a fall in GFR during drug-induced diuresis.

Authors: F L Lieberman; S Ito; T B Reynolds
Journal: J Clin Invest Date: 1969-06 Impact factor: 14.808

8 in total

A rational approach to the treatment of ascites.

1. PROGNOSIS AFTER SURGICAL TREATMENT OF ASCITES: RESULTS OF SIDE-TO-SIDE SHUNT IN 40 PATIENTS.

2. THE KIDNEY IN CIRRHOSIS. II. DISORDERS OF RENAL FUNCTION.

3. Plasma colloid osmotic pressure in relation to the formation of ascites and oedema in liver disease.

4. Renal failure in Laennec's cirrhosis of the liver. I. Description of clinical and laboratory features.

5. Electrolyte and circulatory changes in terminal liver failure.

6. Hyponatremia in hepatic cirrhosis following paracentesis.

7. Complications of diuretic therapy in hepatic cirrhosis.

8. 9- -fluorohydrocortisone induced ascites in alcoholic liver disease.

9. Plasma volume in cirrhosis of the liver: its relation of portal hypertension, ascites, and renal failure.

10. Effective plasma volume in cirrhosis with ascites. Evidence that a decreased value does not account for renal sodium retention, a sponteneous reduction in glomerular filtration rate (GFR), and a fall in GFR during drug-induced diuresis.

1. Treatment of ascites in patients with cirrhosis of the liver.

Review 2. Traditional management of liver disorders.

3. Coagulopathy post peritoneovenous shunt.

Review 4. Outcomes of transjugular intrahepatic portosystemic shunts for ascites.

Review 5. Pharmacotherapy of ascites associated with cirrhosis.

6. Pharmacokinetics of furosemide in patients with hepatic cirrhosis.

Review 7. Evaluation and management of patients with refractory ascites.

8. Lipoprotein profile of pleural and peritoneal transudates in dogs and cats.